Skip to main content
Fig. 1 | BMC Pharmacology and Toxicology

Fig. 1

From: β-Hydroxyphosphocarnitine modifies fibrosis, steatosis and improves liver function in non-alcoholic steatohepatitis induced in rats

Fig. 1

Effect of β-HPC on liver architecture in rats with NASH. Histopathological analysis of liver sections from: A Control group; B β-HPC group; C Non-treated NASH group, showing distortion of hepatic architecture with steatosis (S), and bands of fibrosis (F); D NASH group treated with 100 mg/Kg β-HPC, showing an improvement in liver structure as well as reduced steatosis and fibrosis. Black arrows show presence of microvesicular and macrovesicular steatosis.The liver sections were stained with H&E stain. Magnification 20X and 40X

Back to article page